FDA Investigator George Pyramides
George Pyramides has conducted inspections on 31 sites in 5 countries as of 27 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
31
Last Inspection Date:
27 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
China,
India,
Switzerland,
Spain
FDA Investigators that have inspected at least one site in common with George Pyramides:
Alice S Tsao,
Alicia M Mozzachio,
Alison N Stieg,
Allen Lou,
Amy L Singer,
Amy M Cramer,
Anastasia I Offordile,
Anastasia I Onuorah,
Anastasia M Shields,
Anita Narula, PhD,
Anita R Michael,
Ankur C Patel,
Ann Marie Montemurro,
Anthony A Charity,
Arsen Karapetyan,
Asamoah Asamoah,
Audrey Thereset Uy,
Barbara A Gullick,
Barbara Jwilimczyk Macri,
Bijoy Panicker,
Brian L Belz,
Brian R Yaun,
Brooke K Higgins,
Brooke K Seeman,
Burnell M Henry,
Byungja E Marciante,
Candice C Mandera,
Candice J Cortes,
Carrie A Hughes,
Carrie L Doupnik,
CDR Rochelle B Young, RPh, MSA,
Chaltu Nwakijra,
Charisse K Green,
Charles J Chacko,
Cheryl A Clausen,
Cheryl A Grandinetti,
Chiang Syin, PhD,
Chikako Torigoe, PhD,
Christian D Lynch (CDL),
Christina K Theodorou,
Christina N Maurino,
Christine M Cerenzio,
Chryste D Best,
Clinton J Lott,
Constantin Y Philopoulos,
Craig A Garmendia,
Cynthia Jim, CSO,
Cynthia R Gibson,
Cynthia White,
Dale A Nyberg,
David A Oluwo,
David J Hafner,
David L Pearce,
Dawn L Wydner,
Deborah B Nixon,
Debra J Bennett,
Debra L Pagano,
Denise M Visco, Investigator,
Dennis L Doupnik,
Diane T Bargo,
Diane T O'brien,
Doan T Nguyen, PharmD,
Dolores Harper,
Donald L Lech,
Doreen P Gubbay,
Douglas A Campbell,
Douglas C Kovacs,
Dr. Dominick Roselle,
Dr. Gang Wang, PhD,
Dr. Gerald E Poly,
Dr. Mark J Seaton, PhD,
Dr. Roslyn F Powers,
Dr. S Nar Ali, PhD,
Dr. Sriram Subramaniam, PhD,
Dr. Yubing Tang,
Edmund F Mrak, Jr,
Edward D Mcdonald,
Eileen A Liu,
Emest F Bizjak,
Emmanuel Jramos Maldonado,
Eric L Dong, BS,
Eric Rothschild,
Erika M Wilkerson,
Erika V Butler,
Erin D Mccaffery,
Fabian Nchaparro Rodriguez,
Francis A Guidry,
Frank W Perrella,
Gayle S Lawson,
Gerald B Seaborn, Jr,
Gifford Whitehurst, Jr,
Gloria E Parra,
Gregson A Joseph,
Guerlain Ulysse,
H Ljamilla Selby,
Hala L Selby,
Hala Lj Whetstone,
Hector Jcolon Torres,
Helen B Ricalde,
Helen Verdel,
Holly Brevig,
Ivy E Sweeney,
Jacqueline Mdiaz Albertini,
James L Dunnie, Jr,
James M Mason,
James M Simpson,
James P Mcevoy,
Javier E Santos,
Jean Blackston Hill,
Jean M Kelahan,
Jeen S Min,
Joan A Loreng,
Joel D Hustedt,
John D White,
Jonah S Ufferfilge,
Jonathan W Chapman,
Jose Acruz Gonzalez,
José E Meléndez,
Jose M Cayuela,
Jose R Hernandez,
Joseph F Mcginnis, RPh,
Joseph L Despins, PhD,
Joseph W Matthews,
Joy Rkozlowski Klena,
Julianne C Mccullough,
Junho Pak,
Justin A Boyd,
Justine Tomasso,
Kara D Dobbin,
Karen E D'orazio,
Kassa Ayalew, MD,
Kathleen M Jordan,
Kelli F Dobilas,
Kelli Regente,
Kenneth H Williams,
Kenneth M Gordon,
Kenneth Nieves,
Kevin A Gonzalez,
Kinh Q Mac,
Ko U Min,
Kristen D Evans,
Kristina J Donohue,
Kristina L Conroy,
Kristina Mjoyce Pittman,
Kristy A Zielny,
Kurt A Brorson, PhD,
Larry K Austin,
Lata C Mathew, PhD,
Laurie B Frazier,
Laurimer Kuilan Torres,
Lawrence Harmon, Jr,
LCDR Debra Emerson,
LCDR Susan E Polifko,
Li Li,
Liatte Kreuger, PharmD,
Linda M Hoover,
Lisa Harlan,
Lisa M Bellows,
Lisa M Feola,
Loretta Nemchik,
Lori A Holmquist,
Lori S Lawless,
LTJG Bradley E Benasutti,
Luella J Rossi,
Luis A Dasta,
Lynette P Salisbury,
Marcellinus D Dordunoo,
Marcelo O Mangalindan, Jr,
Marcus A Ray,
Marea K Harmon,
Margaret M Doherty,
Margaret M Sands,
Massoud Motamed,
Matthew A Spataro,
Matthew B Casale,
Matthew M Henciak,
Matthew R Noonan,
Mayar M Mussa,
Melissa D Ray,
Melissa J Garcia,
Melissa T Roy,
Merideth K Rose,
Michael A Charles,
Michael A Taylor,
Michael E Maselli,
Michael Gurbarg,
Michael J Nerz,
Michael R Goga,
Michael R Klapal,
Michael Serrano,
Michael Shanks, MS,
Michele Gottshall,
Michele M Falchek,
Michelle Yclark Stuart,
Morris Paul,
Muralidhara B Gavini, PhD,
Nancy F Scheraga,
Nebil A Oumer,
Nicholas A Violand,
Nicholas P Diorio,
Nicole E Knowlton,
Niketa Patel,
Nina Yang,
Olaide Akinmade,
Pankaj H Amin,
Paraluman S Leonin,
Parul M Patel,
Patricia F Hughes, PhD,
Patrick C Klotzbuecher,
Patrick L Wisor,
Paul L Bellamy,
Peter E Baker,
Peter R Lenahan,
Prabhu P Raju,
Qin Xu,
Rabin N Ghoshal,
Rachael O Oyewole,
Rachel C Harrington,
Reba A Gates,
Rebecca E Dombrowski,
Rebecca Rodriguez,
Regan T Harp,
Regina T Brown,
Reyes Candau Chacon, PhD,
Robert B Shibuya, MD,
Robert D Tollefsen,
Robert G Ruff,
Robert J Maffei,
Robert J Martin,
Robert Jennings,
Rodney T Allnutt,
Roger F Zabinski,
Ronald A Stokes,
Russell J Glapion,
S Lori Brown, PhD MPH,
Sachinkumar V Patel,
Sam Pepe,
Samina S Khan,
Sena G Dissmeyer,
Sharon K Thoma, PharmD,
Shelley L Waring,
Shirshendu K Deb, PhD,
Sidney B Priesmeyer,
Simone E Pitts,
Sinai I Davis,
Stephanie Mangigian, MS/OSH, RN,
Stephanie T Durso,
Stephen D Brown,
Stephen J Koniers,
Stephen J Mottola,
Steven E Kane,
Subramanian Muthukkumar, PhD,
Susan F Laska, MS,
Susan M Jackson,
Susan T Hadman,
Suzanne M Healy,
Suzanne M Muchene,
Syed N Ali,
Tamal K Chakraborti, PhD,
Tammy L Chavis,
Tawny L Colling,
Tekalign Wondimu,
Temar Q Williams,
Teresa I Navas,
Thomas E Friel,
Thomas J Arista,
Thomas R Withers,
Thuy T Nguyen, LCDR,
Tiffani D Wilson,
Tina M Pawlowski,
Tonia F Bernard,
Torrance J Slayton,
Toyin B Oladimeji,
Truong Xuan Nguyen (Andy),
Tyanna N Hadley,
Vesna V Stanoyevitch,
Viviana Matta,
Vivin George,
Vlada Matusovsky,
Walter L Fava,
Wanda Y Fields,
Wanda Y Honeyblue,
Wayne E Seifert,
William A Warnick,
Xianghong Jing (Emily), PhD,
Xiaohan Cai, PhD,
Yangmin Ning,
Yvesna C Blaise,
Yvette I Johnson,
Yvins Dezan,
Yvonne C Mcknight,
Yvonne C Wood,
Zakaria I Ganiyu,
Zedong Dong,
Zhongren Wu,
Zi Qiang Gu
George Pyramides's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more